Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07231640 · ClinicalTrials.gov registry record · NA

PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking

A NA study of HIV and HIV Prevention, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT07231640 is a NA study of HIV and HIV Prevention that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 56 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07231640, a NA study of HIV and HIV Prevention, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to enhance and evaluate the implementation of a PrEP Care Continuum data dashboard across seven distinct clinical sites in Alabama. By leveraging real-time data and fostering collaborative partnerships, this project aims to accurately visualize care disparities, allocate resources strategically, identify and address care gaps in the delivery of PrEP services, and gauge its impact on HIV prevention efforts.

Interventions

  • OTHER PrOTECT AL Implementation Strategy

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2026-02-09
Est. Completion 2030-04
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT07231640

The ClinicalTrials.gov registry entry for NCT07231640 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (87% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which PrOTECT AL Implementation Strategy is the first listed.

NCT07231640 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT07231640 about?

NCT07231640 is a clinical study titled "PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking". The purpose of this study is to enhance and evaluate the implementation of a PrEP Care Continuum data dashboard across seven distinct clinical sites in Alabama. By leveraging real-time data and fostering collaborative partnerships, this project aims to accurately visualize care disparities, allocate...

What is the current status of trial NCT07231640?

This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2026-02-09. Estimated completion is 2030-04.

What conditions does trial NCT07231640 study?

This clinical trial studies the following conditions: HIV, HIV Prevention, PrEP, PrEP Uptake.

What interventions are being tested in trial NCT07231640?

The interventions under investigation include: PrOTECT AL Implementation Strategy (OTHER).

Who is sponsoring clinical trial NCT07231640?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07231640 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.